Breaking News, Collaborations & Alliances

Nanoform, Celanese Demonstrate Enhanced Drug Delivery Technology

Alliance aims to enable enhanced sustained release properties by reducing the initial burst release of a drug.

Nanoform Finland Plc, a nanoparticle medicine enabling company, and Celanese Corporation, a global specialty materials company, presented an update on their collaboration to evaluate the synergies between their respective technologies in the field of nanoparticle-enabled drug delivery. Together, the API nanoparticles produced through Nanoform’s CESS technology and the Celanese VitalDose EVA copolymer delivery technology for drug-eluting implants have the potential to enable enhanced sustained...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters